Treatment of basal cell carcinoma
Authors:
- 17 November 2009
- journal article
- review article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 7 (12) , 1075-1083
Abstract
Summary: Basal cell carcinoma is the most common tumor in Central Europe, the U.S. and Australia. The increasing incidence of basal cell carcinoma presents the health care system, especially dermatology, with great challenges. In recent years new options for treating basal cell carcinoma have become available, enriching our therapeutic options. We review the current status of each of these treatment approaches.Keywords
This publication has 26 references indexed in Scilit:
- Short German guidelines: basal cell carcinoma.JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2008
- Kurzleitlinie: Basalzellkarzinom der HautJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2006
- Contribution of stem cells and differentiated cells to epidermal tumoursNature Reviews Cancer, 2003
- Micrographic Surgery of Basal Cell Carcinomas of the Head2002
- Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus SyndromeScience, 1996
- Metastatic basal cell carcinoma. Report of five casesCancer, 1994
- Prediction of Subclinical Tumor Infiltration in Basal Cell CarcinomaThe Journal of Dermatologic Surgery and Oncology, 1991
- The risk of developing subsequent nonmelanoma skin cancersJournal of the American Academy of Dermatology, 1990
- Trends in the Presentation and Treatment of Basal Cell CarcinomasThe Journal of Dermatologic Surgery and Oncology, 1986
- Mohs SurgeryArchives of Dermatology, 1983